.svg)
Dabigatran Etexilate Capsules 75 Mg
Price range: $108.00 through $270.00
Dabigatran Etexilate 75 Mg is a low-dose oral anticoagulant used to prevent and treat blood clots in atrial fibrillation, DVT, and pulmonary embolism. It works by inhibiting thrombin, reducing stroke risk. This dose is commonly used for patients requiring dose adjustment or with higher bleeding risk under medical supervision.
Description
Dabigatran Etexilate Capsules 75 Mg
Dabigatran Etexilate Capsules 75 Mg is an oral anticoagulant used to prevent and treat blood clots in conditions such as atrial fibrillation, deep vein thrombosis (DVT), and pulmonary embolism (PE). This lower strength is typically prescribed for dose adjustment, especially in patients with kidney impairment or higher bleeding risk.
Mechanism of Action
Direct Thrombin Inhibition
Dabigatran blocks thrombin, an enzyme essential for blood clot formation.
Clot Prevention
It prevents fibrin clot formation, reducing the risk of stroke and thrombosis.
Medical Uses
Dabigatran 75 Mg is used for:
- Stroke prevention in atrial fibrillation
- Treatment and prevention of DVT
- Treatment and prevention of pulmonary embolism
Dosage and Administration
It is taken orally, usually twice daily, as prescribed. Capsules should be swallowed whole with water and not crushed or chewed. This lower dose is often used in patients requiring cautious anticoagulation or dose adjustment.
Clinical Effectiveness
Clinical evidence shows that dabigatran provides reliable anticoagulation and helps reduce clot-related complications when used consistently under medical supervision.
Safety and Side Effects
Common Side Effects
- Indigestion
- Stomach discomfort
- Mild bleeding
Serious Risks
- Severe bleeding
- Gastrointestinal bleeding
Regular monitoring is important during therapy.
Higher strengths such as Dabigatran Etexilate Capsules 150 Mg are used for standard anticoagulation, while alternatives like Pradaxa 110 Mg may be prescribed based on patient condition and bleeding risk.
Contraindications and Precautions
Dabigatran should be used with caution in:
- Patients with kidney disease
- Individuals with bleeding disorders
- Patients undergoing surgery
Proper medical evaluation is required before use.
Drug Interactions
Dabigatran may interact with other anticoagulants, antiplatelet drugs, and medicines affecting bleeding risk. Patients should inform their healthcare provider about all medications they are taking.
For clinical guidelines and safety information, refer to American Heart Association (AHA) and Mayo Clinic – Dabigatran Drug Information.
FAQs
Dabigatran 75 Mg is used to prevent stroke in atrial fibrillation and to treat or prevent deep vein thrombosis and pulmonary embolism. It is often prescribed as a lower dose for patients with higher bleeding risk or kidney impairment to ensure safe anticoagulation therapy.
Dabigatran works by inhibiting thrombin, an enzyme necessary for blood clot formation. By blocking thrombin, it prevents fibrin clot development. This helps maintain proper blood flow and reduces the risk of stroke and clot-related complications in patients requiring anticoagulation treatment.
It should be taken orally, usually twice daily, as prescribed. Capsules must be swallowed whole with water and not crushed or chewed. Taking it consistently at the same time each day ensures effective anticoagulation and reduces the risk of clot formation.
It is generally safe when used under medical supervision but carries a risk of bleeding. Regular monitoring and proper dosing are important. Patients should report any unusual bleeding or symptoms to their doctor to ensure safe and effective use.
Common side effects include indigestion, stomach discomfort, and mild bleeding such as bruising or nosebleeds. These are usually manageable. Serious side effects include severe bleeding, which requires immediate medical attention and monitoring during treatment.
RELATED PRODUCTS
Dabigatran Etexilate Capsules 150 Mg
